Sorry, you need to enable JavaScript to visit this website.

LORBRENA® (lorlatinib) Contraindications

4 CONTRAINDICATIONS

LORBRENA is contraindicated in patients taking strong CYP3A inducers, due to the potential for serious hepatotoxicity [see Warnings and Precautions (5.1)].

What's New

No Current Announcements.

Contact Pfizer Medical

Report an Adverse Event
1-800-438-1985

Search

Please enter your search term(s) for LORBRENA®